Roche's Franz Humer is stepping down as chief executive to concentrate on his role as chairman.In splitting the top jobs, …
Swiss pharma company Novartis has posted sales growth of 14% for the first half of 2007, but growing pressure from …
UK Alzheimer's patients may not lose access to drug treatment, despite restrictive NICE guidance.Prescribing of Alzheimer's drugs has increased by …
Bayer has officially launched its new UK pharmaceutical division, following last year's acquisition of Schering Health Care.Called Bayer Schering Pharma, …
After 18 months of deliberation by an expert committee, the UK government has agreed in principle that girls aged 12-13 …
A patient group is urging doctors to exercise their clinical judgement to overrule NICE guidance which restricts access to Alzheimer's …
An unprecedented legal action by the pharmaceutical industry against the government could reach the High Court within the next few …
Antisoma drops ovarian cancer drugCancer drug developer Antisoma says new data from its Phase II trial of ASA404 showed that …
There is a much-quoted statistic, which has become so hackneyed that it's largely ignored these days, but while you are …
A review of the NHS in London has recommended setting up a network of 150 'polyclinics' to take on much …
The FDA has approved Novartis' Exelon Patch, the first ever skin patch treatment for Alzheimer's disease.Novartis said the once-daily treatment …
The world’s largest private healthcare PR firm Chandler Chicco Agency has been bought out by US marketing group inVentiv Health …
Piramed and Domainex are among the cutting-edge companies which have been recognised as the best of the UKs biotech sector.UK …
Janssen-Cilag's once-daily schizophrenia treatment, Invega, has been granted European approval, making it the first oral, prolonged-release drug for the condition …
Patients with the deadly type of lung cancer called mesothelioma will now be able to receive Lilly's Alimta after NICE …
Vorsprung durch technik? Technological advances have allowed employees to spend increasing amounts of time working remotely away from the office. …
Genzyme says osteoarthritis treatment misses trial goalsGenzyme has reported that its trial of hylastan in treating pain in patients with …
The UK pharmaceutical industry has announced plans to take legal action against the government over the way it controls how …
One of the world's leading surgeons, Professor Ara Darzi, has been handed the task of conducting a major new review …
Dementia is being given far too low a priority by health and social services in the UK, despite a rapid …